Trademark: 88830164
Status Date
Monday, April 3, 2023
Filing Date
Wednesday, March 11, 2020
Published for Opposition
Tuesday, January 5, 2021
Abandoned Date
Monday, April 3, 2023
5 Pharmaceutical and biotechnology products, namely, therapeutic anti-cancer drugs; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for use in oncology
Apr 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 3, 2023
Abandonment - No Use Statement Filed
Sep 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 2, 2022
Sou Extension 3 Granted
Sep 2, 2022
Sou Extension 3 Filed
Sep 2, 2022
Teas Extension Received
Mar 3, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2022
Sou Extension 2 Granted
Mar 1, 2022
Sou Extension 2 Filed
Mar 1, 2022
Teas Extension Received
Sep 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 30, 2021
Sou Extension 1 Granted
Aug 30, 2021
Sou Extension 1 Filed
Aug 30, 2021
Teas Extension Received
Mar 2, 2021
Noa E-Mailed - Sou Required From Applicant
Jan 5, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 5, 2021
Published For Opposition
Dec 16, 2020
Notification Of Notice Of Publication E-Mailed
Dec 3, 2020
Approved For Pub - Principal Register
Dec 2, 2020
Teas/Email Correspondence Entered
Dec 1, 2020
Correspondence Received In Law Office
Dec 1, 2020
Teas Response To Office Action Received
Jun 16, 2020
Teas Change Of Correspondence Received
Jun 16, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Jun 16, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 16, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 3, 2020
Notification Of Non-Final Action E-Mailed
Jun 3, 2020
Non-Final Action E-Mailed
Jun 3, 2020
Non-Final Action Written
Jun 2, 2020
Assigned To Examiner
Mar 17, 2020
New Application Office Supplied Data Entered
Mar 14, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
